High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5234-5239

  Ricker, Lukas J A G ^a,b   Dieri, Raed Al ^c   Beckers, Gerold J M ^d   Pels, Elisabeth ^e   Liem, Albert T A ^a   Hendrikse, Fred ^a   Kijlstra, Aize ^a   Hemker, H Coenraad ^c   la Heij, Ellen C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b European Graduate School for Neuroscience   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; THROMBOPLASTIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RHEGMATOGENOUS RETINA DETACHMENT; SCLERA BUCKLING PROCEDURE; SUBRETINAL FLUID; THROMBOGENICITY; VITREOUS BODY; WESTERN BLOTTING; ADOLESCENT; BODY FLUID; COMPARATIVE STUDY; EXUDATE; METABOLISM; MIDDLE AGED; RETINA MACULA DEGENERATION; RETINA TEAR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BODY FLUIDS; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETINAL PERFORATIONS; SCLERAL BUCKLING; THROMBIN; THROMBOPLASTIN; VITREOUS BODY; YOUNG ADULT;

EID: 77958137479     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5354     Document Type: Article

References (23)

1. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA. 1977;74: 5260-5264.
2. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
3. Koyama T, Nishida K, Ohdama S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol. 1994;87:343-347.
4. Sakamoto T, Ito S, Yoshikawa H, et al. Tissue factor increases in the aqueous humor of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2001;239:865-871.
5. Hollborn M, Francke M, Iandiev I, et al. Early activation of inflammation- and immune response-related genes after experimental detachment of the porcine retina. Invest Ophthalmol Vis Sci. 2008;49:1262-1273.
6. Brozna JP. Cellular regulation of tissue factor. Blood Coagul Fibrinolysis. 1990;1:415-426.
7. Cleary PE, Ryan SJ. Experimental posterior penetrating eye injury in the rabbit, I: method of production and natural history. Br J Ophthalmol. 1979;63:306-311.
8. García-Layana A, Pastor JC, Saornil MA, Gonzalez G. Porcine model of proliferative vitreoretinopathy with platelets. Curr Eye Res. 1997;16:556-563.
9. Hemker HC, Giesen P, Al Dieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249-253.
10. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4-15.
11. Yoshino Y, Ideta H, Nagasaki H, Uemura A. Comparative study of clinical factors predisposing patients to proliferative vitreoretinopathy. Retina. 1989;9:97-100.
12. Girard P, Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 1994;14:417-424.
13. Muth H, Kreis I, Zimmermann R, Tillmanns H, Hölschermann H. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor. Thromb Haemost. 2005;94:1028-1034.
14. Siegbahn A, Johnell M, Rorsman C, Ezban M, Heldin CH, Rönnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood. 2000;96:3452-3458.
15. Hoffman M. Some things I thought I knew about tissue factor that turn out to be wrong. Thromb Res. 2008;122(suppl 1):S73-S77.
16. Feeney L, Burns RP, Mixon RM. Human subretinal fluid: its cellular and subcellular components. Arch Ophthalmol. 1975;93:62-69.
17. Satoh Y. Retinal circulation in rhegmatogenous retinal detachment demonstrated by videofluorescence angiography and image analysis, I: The condition of retinal circulation before retinal detachment surgery (in Japanese). Nippon Ganka Gakkai Zasshi. 1989; 93:1002-1008.
18. Tagawa H, Feke GT, Goger DG, McMeel JW, Furukawa H. Retinal blood flow changes in eyes with rhegmatogenous retinal detachment and scleral buckling procedures (in Japanese). Nippon Ganka Gakkai Zasshi. 1992;96:259-264.
19. Weller M, Wiedemann P, Bresgen M, Heimann K. Giant preretinal membrane formation behind a silicone oil bubble in a hypotensive eye. Retina. 1990;10:86-91.
20. Schwartz D, de la Cruz ZC, Green WR, Michels RG. Proliferative vitreoretinopathy: ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina. 1988;8:275-281.
21. Vidaurri-Leal JS, Glaser BM. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1376-1379.
22. Østerud B, Bjørklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;32:11-23.
23. Egorina EM, Sovershaev MA, Bjørkøy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol. 2005;25: 1493-1498.